Related by context. Frequent words. (Click for all words.) 71 BUY recommendation 71 Speculative Buy 62 Outperform recommendation 61 SVNT 61 Underweight rating 60 BUY rating 60 Oppenheimer NYSE OPY 60 VPHM 60 Underperform recommendation 59 SELL rating 59 Underperform rating 59 HOLD recommendation 59 Equalweight 59 Neutral rating 59 SLXP 58 REGN 58 Overweight rating 58 ALTH 58 Taglich Brothers 58 INCY 57 BMRN 57 Guides FY# Quick Facts 57 Outperform rating 57 Market Perform rating 57 FY# EPS estimate 56 Outperform Rating 56 MYGN 56 SANM 56 OXPS 56 ADCT 56 PRGO 55 KRChoksey 55 CNXT 55 NYSE PJC 55 #.#/share [004] 55 GPRO 54 AMLN 54 Inc. NASDAQ BIIB 54 Equal Weight rating 54 Neutral recommendation 53 Inc ticker 53 SYK 53 SIGM 53 BUY 53 % SELL OFF 53 Hold rating 53 ONXX 53 Options Trader Alert 52 Underperform 52 Ardea Biosciences 52 BLUD 52 SHARES COULD POTENTIALLY PULLBACK 52 Posts Large Volume Increase 52 Celgene CELG 52 HOLD rating 52 Outperform 52 CHKP 52 Lazard Capital 52 FY# EPS 52 Human Genome Sciences HGSI 52 Interesting Options Volume 52 ALXN 52 Options Activity 52 CROSSES PIVOT POINT SUPPORT 52 ISLN 52 outperform rating 51 Share Buyback 51 Neutral Rating 51 Bullish Engulfing Pattern 51 Sector Perform 51 OFFERS INVESTORS BETTER VALUE 51 GENZ 51 LNCR 51 THE TREND CONTINUES DOWN 51 NYSE RY 51 CPKI 51 ADTN 51 AVANIR Pharmaceuticals 51 Analysts Begin Coverage 51 APPROACHES NEW UPSIDE TARGET 51 #/share [001] 51 MXIM 51 O2Micro International 51 THE TREND CONTINUES LOWER 51 PSYS 51 Cypress Bioscience 51 BREAKS THROUGH RESISTANCE AT 50 Inc. NASDAQ BIDU 50 ISIL 50 EPS Guidance 50 Conviction Buy List 50 NEXT RESISTANCE LEVEL FOR 50 THQI 50 CWTR 50 Market Perform 50 underperform rating 50 GNTX 50 GYMB 50 Downside Target 50 Q3 Loss Narrows 50 NTRI